Search | TVST | ARVO Journals

View

Showing 1 – 9 of 9

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2021

Ocular Graft vs Hosts Disease (oGVHD) After Allogenic Hematopoietic Stem Cell Transplant (allo-HSCT): A 2 Year Longitudinal, Observational Study

Nour Atassi; Bayasgalan Surenkhuu; Jessica Mun; Caitlin Berek; Anna Ahn; Nikhil Dhall; Christian Kim; Sarah Abdul-Hadi; Anubhav Pradeep; Christine Mun; Sandeep Jain

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1244.

ARVO Annual Meeting Abstract July 2019

Recombinant Deoxyribonuclease (DNase) Eye Drops Use in Patients with Dry Eye Disease: Results of a Randomized Clinical Trial

Christine Mun; Sapna Tibrewal; Anna Ahn; Azucena Lopez; Nour Atassi; Bayasgalan Surenkhuu; Morgan Buwick; Hirali Shah; Shivali Shukla; Jessica Mun; Anubhav Pradeep; Illangovan Raju; Sandeep Jain

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6759.

Clinical Trials May 2019

A Phase I/II Placebo-Controlled Randomized Pilot Clinical Trial of Recombinant Deoxyribonuclease (DNase) Eye Drops Use in Patients With Dry Eye Disease

PDF

Christine Mun; Shilpa Gulati; Sapna Tibrewal; Yi-Fan Chen; Seungwon An; Bayasgalan Surenkhuu; Ilangovan Raju; Morgan Buwick; Anna Ahn; Ji-Eun Kwon; Nour Atassi; Anubhav Pradeep; Damiano Rondelli; Sandeep Jain
TAGS: deoxyribonucleases, dry eye syndromes, eyedrops, placebos, deoxyribonuclease i
Trans. Vis. Sci. Tech.. 2019; 8(3):10. https://doi.org/10.1167/tvst.8.3.10

ARVO Annual Meeting Abstract July 2018

Oncostatin M (OSM) Contributes to Corneal Epitheliopathy in Tear Deficient Dry Eye Disease due to Chronic ocular Graft-Vs-Host Disease (oGVHD)

Christine Mun; SEUNGWON AN; ILANGOVAN RAJU; Bayasgalan Surenkhuu; Satyabrata Sinha; Pei-Yu Wu; Anubhav Pradeep; Anna Ahn; Jieun Kwon; Azucena Lopez; Sandeep Jain

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3292.

ARVO Annual Meeting Abstract July 2018

Sub-Anticoagulant Dose Heparin is a Potential Therapy for Tear Deficient Dry Eye Disease in patients with ocular Graft-Vs-Host Disease (oGVHD).

SEUNGWON AN; ILANGOVAN RAJU; Bayasgalan Surenkhuu; Satyabrata Sinha; Pei-Yu Wu; Anna Ahn; Anubhav Pradeep; Jieun Kwon; Azucena Lopez; Christine Mun; Sandeep Jain

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3293.

ARVO Annual Meeting Abstract June 2017

A Sema7a derived RTS-disintegrin peptide binds to integrin alpha1beta1 and promotes migration of myeloid-derived suppressor cells (MDSCs)

Pei-Yu Wu; SEUNGWON AN; Hyun Lee; Disha Varma; Eunjae Kim; Zhiqiang Liu; Joy Sarkar; Anubhav Pradeep; Anna Ahn; Christine Mun; Azucena Lopez; ILANGOVAN RAJU; Sandeep Jain

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):152.

ARVO Annual Meeting Abstract June 2017

Semaphorin 7a is differentially expressed in myeloid-derived suppressor cells (MDSCs) under naïve and inflammatory conditions.

SEUNGWON AN; Eunjae Kim; Disha Varma; ILANGOVAN RAJU; Anubhav Pradeep; Christine Mun; Anna Ahn; Azucena Lopez; Zhiqiang Liu; Sandeep Jain

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):153.

ARVO Annual Meeting Abstract June 2017

Neutrophil Extracellular Traps (NETs) delay Epithelial Wound Healing in-vitro: Implications in chronic Ocular GVHD

Satyabrata Sinha; ILANGOVAN RAJU; SEUNGWON AN; Anubhav Pradeep; Bayasgalan Surenkhuu; Anisha D’costa; Pei-Yu Wu; Shilpa Gulati; Azucena Lopez; Christine Mun; Anna Ahn; Sandeep Jain

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):160.

ARVO Annual Meeting Abstract June 2017

Tear fluid neutrophils and NETs: Implications in the pathogenesis of ocular graft vs host disease

ILANGOVAN RAJU; SEUNGWON AN; Disha Varma; Anubhav Pradeep; Bayasgalan Surenkhuu; Azucena Lopez; Anisha D'costa; Christine Mun; Anna Ahn; Satyabrata Sinha; Shilpa Gulati; Sandeep Jain

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3934.

Advertisement